FR1284M - Medicinal product for the treatment of primary hypogonadotrophic amenorrhea and related conditions. - Google Patents

Medicinal product for the treatment of primary hypogonadotrophic amenorrhea and related conditions.

Info

Publication number
FR1284M
FR1284M FR866549A FR866549A FR1284M FR 1284 M FR1284 M FR 1284M FR 866549 A FR866549 A FR 866549A FR 866549 A FR866549 A FR 866549A FR 1284 M FR1284 M FR 1284M
Authority
FR
France
Prior art keywords
hypogonadotrophic
amenorrhea
primary
treatment
related conditions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR866549A
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Serono SpA
Original Assignee
Istituto Farmacologico Serono SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Istituto Farmacologico Serono SpA filed Critical Istituto Farmacologico Serono SpA
Priority to FR866549A priority Critical patent/FR1284M/en
Application granted granted Critical
Publication of FR1284M publication Critical patent/FR1284M/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
FR866549A 1961-06-28 1961-06-28 Medicinal product for the treatment of primary hypogonadotrophic amenorrhea and related conditions. Expired FR1284M (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR866549A FR1284M (en) 1961-06-28 1961-06-28 Medicinal product for the treatment of primary hypogonadotrophic amenorrhea and related conditions.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR866549A FR1284M (en) 1961-06-28 1961-06-28 Medicinal product for the treatment of primary hypogonadotrophic amenorrhea and related conditions.

Publications (1)

Publication Number Publication Date
FR1284M true FR1284M (en) 1962-05-02

Family

ID=87846549

Family Applications (1)

Application Number Title Priority Date Filing Date
FR866549A Expired FR1284M (en) 1961-06-28 1961-06-28 Medicinal product for the treatment of primary hypogonadotrophic amenorrhea and related conditions.

Country Status (1)

Country Link
FR (1) FR1284M (en)

Similar Documents

Publication Publication Date Title
FR1369M (en) New products for the treatment of visual acuity.
FR3845M (en) New drug in particular for the treatment of hypercholesterolemia and the resulting disorders.
FR1438M (en) New drug effective in the treatment of atherosclerosis.
FR1284M (en) Medicinal product for the treatment of primary hypogonadotrophic amenorrhea and related conditions.
FR2354M (en) Composition based on steroids and 2-methyl-3-indolyl-aliphatic acid for the treatment of inflammation.
FR1489M (en) 4,4 'substituted diphenlysulfones and pharmaceutical preparations thereof for the treatment of viral diseases.
FR2048M (en) Therapeutic agent containing solubilized hydrocortisone acetate for the treatment of inflammatory diseases.
FR1204M (en) New drug, in particular for the treatment of chronic or post-prandial hyperlipemia.
FR1143M (en) Medicinal product based on a pyimidic derivative, in particular for the treatment of hypercholesterolemia and hyper-uricemia.
FR2929M (en) Pharmaceutical composition for the treatment of arthritic and rheumatic conditions.
FR1857M (en) New drug in particular for the treatment of diseases of viral origin.
FR1780M (en) New drug in particular for the treatment of disorders of protein anabolism.
FR1122M (en) New drug in particular for the treatment of hypercholesterolemia.
FR3392M (en) Dermatological medicinal product, in particular for the treatment of oozing eczema.
FR3532M (en) New drug, in particular for the treatment of hypercholesterolemia and the resulting disorders.
FR1039M (en) Ribonuclease-based medicine for the treatment of psoriasis and other dermatoses.
FR2789M (en) New drug in particular for the treatment of hypercholesterolemia and the resulting disorders.
FR151M (en) New drug, in particular for the treatment of neuro-depressive states and anxiety psychoses.
FR1830M (en) New drug in particular for the treatment of follicle-stimulating hyperactivity.
FR3419M (en) New drugs, in particular for the treatment of neuro-depressive states and anxiety psychoses.
FR1596M (en) Drug for the treatment of alcoholism.
BE630069A (en) Therapeutic composition for the treatment of parkinsonism.
FR1288M (en) New drug, in particular for the treatment of postprandial or acute hyperlipemia.
FR1512M (en) New drug in particular for the treatment of arterial hypertension.
FR1466M (en) New drug in particular for the treatment of arterial hypertension.